Interferon Beta-1b for Multiple Sclerosis: Service Provision Promoting Therapy Adherence in Queensland, Australia
نویسندگان
چکیده
منابع مشابه
Application of Interferon Beta-1b in Multiple Sclerosis
Recombinant interferon beta-1b (IFNβ-1b) was the first approved disease-modifying therapy for patients with multiple sclerosis (MS) by the world regulatory agencies for medical drugs and devices. IFNβ-1b significantly decreases the inflammatory component of MS but still has doubtable effect on the neurodegenerative component. This article appraises the beneficial effects of IFNβ-1b on clinical ...
متن کاملP 52: Interferon beta-a1 vs. Teriflunomide for Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory disorder, in which neurons in central nervous system (CNS) become demyelinated .MS is named for its formation of plaques due to sclerosis of myelin. Variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. It is commonly characterized by recurrent relapses and often followed by severe neurological disabi...
متن کاملNeutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
Biological drugs that have a protein or peptide structure provide new and highly eff e c t i v e therapies for a number of conditions and diseases, but their prolonged use in patients gives rise to new problems and questions, amongst them the possible occurrence of neutralizing antibodies (Nabs). We discuss some aspects of this particular problem in relation to interferon-beta therapy of multip...
متن کاملreversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
no abstract
متن کاملAdherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
BACKGROUND Adherence to interferon β-1b (INFβ-1b) therapy is essential to maximize the beneficial effects of treatment in multiple sclerosis (MS). For that reason, the main objectives of this study are to assess adherence to INFβ-1b in patients suffering from MS in Spain, and to identify the factors responsible for adherence in routine clinical practice. METHODOLOGY/PRINCIPAL FINDINGS This wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of MS Care
سال: 2006
ISSN: 1537-2073
DOI: 10.7224/1537-2073-8.3.107